Articles by C Lu (6)

An investigation into the population abundance distribution of mRNAs, proteins, and metabolites in biological systems

C Lu and R. D. King

Bioinformatics 25 ( 16 ): 2020 - 2027 , 2009

Inhibition of mTORC1 signaling reduces tumor growth but does not prevent cancer progression in a mouse model of thyroid cancer

C. J Guigon, L Fozzatti, C Lu, M. C Willingham and S. y. Cheng

Carcinogenesis 31 ( 7 ): 1284 - 1291 , 2010

Multiple roles for CCR2 during fracture healing

Z Xing, C Lu, D Hu, Y. y Yu, X Wang, C Colnot, M Nakamura, Y Wu, T Miclau and R. S. Marcucio

Disease Models and Mechanisms 3 ( 7-8 ): 451 - 458 , 2010

The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America

S. W Grimm, H. J Einolf, S. D Hall, K He, H. K Lim, K. H. J Ling, C Lu, A. A Nomeir, E Seibert, K. W Skordos, G. R Tonn, R Van Horn, R. W Wang, Y. N Wong, T. J Yang and R. S. Obach

Drug and Therapeutics Bulletin 37 ( 7 ): 1355 - 1370 , 2009

The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America

S. W Grimm, H. J Einolf, S. D Hall, K He, H. K Lim, K. H. J Ling, C Lu, A. A Nomeir, E Seibert, K. W Skordos, G. R Tonn, R Van Horn, R. W Wang, Y. N Wong, T. J Yang and R. S. Obach

Drug Metabolism and Disposition 37 ( 7 ): 1355 - 1370 , 2009

EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma

J. W Lee, H. D Han, M. M. K Shahzad, S. W Kim, L. S Mangala, A. M Nick, C Lu, R. R Langley, R Schmandt, H. S Kim, S Mao, J Gooya, C Fazenbaker, D Jackson, D. A Tice, C. N Landen, R. L Coleman and A. K. Sood

JNCI J Natl Cancer Inst 101 ( 17 ): 1193 - 1205 , 2009

Do you have a suggestion for journals

Suggest Journal